KLRG1

KLRG1

KLRG1 Informations sur la molécule

Molecule Name
Killer cell lectin-like receptor subfamily G member 1
Alias de la molécule
KLRG1
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 3 Clinical
Alias de la cible
C-type lectin domain family 15 member A,ITIM-containing receptor MAFA-L,MAFA-like receptor,Mast cell function-associated antigen,CLEC15A,MAFA,MAFAL
Contexte de la molécule
The co-inhibitory receptor killer-cell lectin like receptor G1 (KLRG1) is specifically expressed on NK cells and activated CD8+ T-cells and has been postulated to be a marker of senescence. KLRG1+ T cells are a major reason of chronic tissue damage in some autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. In tumors, tumor cells which express E-cadherin or N-cadherin bind to KLRG1 and inhibit the antitumor activity of T and NK cells. Thus, KLRG1 acts as an immunocheckpoint inhibitory receptor.

KLRG1 Liste de produits

Species
  • Cynomolgus(3)
  • Human(1)
  • Mouse(1)
Tag
  • His Tag(3)
  • Fc Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(5)
Conjugate
  • Unconjugated(4)
  • Biotin-labeled(1)
Grade
  • RUO(5)
Low Endotoxin
  • No(5)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
KLRG1
Cynomolgus KLRG1 Protein, His Tag (SPR verified)
Cynomolgus
HEK293
SDS-PAGE
SPR

$360.00

100ug
KLRG1
Mouse KLRG1 Protein, His Tag (MALS & SPR verified)
Mouse
HEK293
MALSSDS-PAGE
ELISASPR

$360.00

100ug
KLRG1
Cynomolgus KLRG1 Protein, Fc Tag (SPR verified)
Cynomolgus
HEK293
SDS-PAGE
SPR

$360.00

100ug
KLRG1
Human KLRG1 Protein, His Tag
Human
HEK293
SDS-PAGE

$380.00

100ug
KLRG1
Avitag
KL1-C82Q4
Biotinylated Cynomolgus KLRG1 Protein, Avitag™,His Tag
Cynomolgus
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-5 Of 5 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
UlviprubartABC008; ABC-008Phase 3 ClinicalAbcuro Inc
Leukemia, Large Granular Lymphocytic; Myositis, Inclusion Body
Details
Customer Reviews